EDGAR Filing Documents for 9999999995-17-003015

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-17-003015

Accepted

2017-11-20 00:15:13

Documents

Effectiveness Date

2017-11-17

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	592
	Complete submission text file	9999999995-17-003015.txt		1783

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: EFFECT | Act: 33 | File No.: 333-221275 | Film No.: 171212533
SIC: 2834 Pharmaceutical Preparations